Edward Charbek is a Respiratory physician affiliated with Saint Louis University. OpenAlex indexes 50 publications with 544 citations (h-index 9).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1402 S Grand Blvd
Fdt 14 Floor
Saint Louis, MO 631041004
Telephone
314-577-8762Provider last certified this registry record 11 Apr 2025.
Industry payments
11 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- GENZYME CORPORATIONProgram year202543 payments$68,829openpaymentsdata.cms.gov ↗
- Regeneron Healthcare Solutions, Inc.Program year202520 payments$27,811openpaymentsdata.cms.gov ↗
- Verona Pharma, Inc.Program year202513 payments$15,097openpaymentsdata.cms.gov ↗
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Respiratory
100%beta2-Adrenergic Agonist41.8%Albuterol Sulfate Hfa72%Ventolin Hfa28%Part D<11 patientsCorticosteroid34.3%Breztri Aerosphere31%Trelegy Ellipta24%Breo Ellipta16%Symbicort15%Breyna13%Part D<11 patients+ 2 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Detection of Bronchiolitis Obliterans Syndrome after Pediatric Hematopoietic Stem Cell Transplantation: An Official American Thoracic Society Clinical Practice Guideline
American Journal of Respiratory and Critical Care Medicine
2024 - Diagnosis of Post-Hematopoietic Stem Cell Transplantation Bronchiolitis Obliterans Syndrome in Children: Time for a Rethink?
Biology of Blood and Marrow Transplantation
2024 - Role of Monoclonal Antibodies in the Management of Eosinophilic Chronic Obstructive Pulmonary Disease: A Meta-Analysis of Randomized Controlled Trials
Annals of the American Thoracic Society
2024
Similar KOLs
Other experts from the same institution or the same specialty.
Ravi Vij
Saint Louis University
Robert Belshe, MD
Saint Louis University
Geoffrey L. Uy
Saint Louis University
Mark Dykewicz, MD
Saint Louis University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”